•  
  •  
 

Volume 5, Issue 4 (2026)

Original Study

PDF

Dose-dependent pharmacodynamic interaction between fasudil, a Rho kinase inhibitor, and doxorubicin in the MCF-7 breast cancer cell line
Ahmed B. Abdulwahid, Shaymaa F. Abbas, Dhuha E. Omran, Nehaya M. Al-Aubody, and Sara A. Yaseen